Search research articles
Contact Us
Filters
Showing results (51-60 of 126) with videos related to
Page
of 13
Sort By:
Journal of Medicinal Chemistry
|
October 24, 2023
Fused Tetrahydroquinolines Are Interfering with Your Assay
Frances M Bashore, Joel Annor-Gyamfi, Yuhong Du, et al.
Journal of Medicinal Chemistry
|
July 26, 2011
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines
Feng Liu, Dalia Barsyte-Lovejoy, Abdellah Allali-Hassani, et al.
Journal of Medicinal Chemistry
|
March 1, 2013
Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors
Feng Liu, Fengling Li, Anqi Ma, et al.
Scientific Reports
|
April 27, 2019
Discovery of selective activators of PRC2 mutant EED-I363M
Junghyun L Suh, Kimberly D Barnash, Tigran M Abramyan, et al.
Plos One
|
October 27, 2016
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
Alexandra Sufit, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
Nature Communications
|
May 1, 2019
Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing
Hagar F Moussa, Daniel Bsteh, Ramesh Yelagandula, et al.
European Journal of Medicinal Chemistry
|
May 26, 2021
UNC5293, a potent, orally available and highly MERTK-selective inhibitor
Hongchao Zheng, Jichen Zhao, Bing Li, et al.
ACS Combinatorial Science
|
February 7, 2017
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2
Kimberly D Barnash, Juliana The, Jacqueline L Norris-Drouin, et al.
The Journal of Clinical Investigation
|
June 16, 2022
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer
Dan Yan, Justus M Huelse, Dmitri Kireev, et al.
Journal of Medicinal Chemistry
|
October 10, 2013
Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP
Feng Liu, Dalia Barsyte-Lovejoy, Fengling Li, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 126) with videos related to
Sort By:
Page
of 13
Journal of Medicinal Chemistry
|
October 24, 2023
Fused Tetrahydroquinolines Are Interfering with Your Assay
Frances M Bashore, Joel Annor-Gyamfi, Yuhong Du, et al.
Journal of Medicinal Chemistry
|
July 26, 2011
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines
Feng Liu, Dalia Barsyte-Lovejoy, Abdellah Allali-Hassani, et al.
Journal of Medicinal Chemistry
|
March 1, 2013
Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors
Feng Liu, Fengling Li, Anqi Ma, et al.
Scientific Reports
|
April 27, 2019
Discovery of selective activators of PRC2 mutant EED-I363M
Junghyun L Suh, Kimberly D Barnash, Tigran M Abramyan, et al.
Plos One
|
October 27, 2016
MERTK Inhibition Induces Polyploidy and Promotes Cell Death and Cellular Senescence in Glioblastoma Multiforme
Alexandra Sufit, Alisa B Lee-Sherick, Deborah DeRyckere, et al.
Nature Communications
|
May 1, 2019
Canonical PRC1 controls sequence-independent propagation of Polycomb-mediated gene silencing
Hagar F Moussa, Daniel Bsteh, Ramesh Yelagandula, et al.
European Journal of Medicinal Chemistry
|
May 26, 2021
UNC5293, a potent, orally available and highly MERTK-selective inhibitor
Hongchao Zheng, Jichen Zhao, Bing Li, et al.
ACS Combinatorial Science
|
February 7, 2017
Discovery of Peptidomimetic Ligands of EED as Allosteric Inhibitors of PRC2
Kimberly D Barnash, Juliana The, Jacqueline L Norris-Drouin, et al.
The Journal of Clinical Investigation
|
June 16, 2022
MERTK activation drives osimertinib resistance in EGFR-mutant non-small cell lung cancer
Dan Yan, Justus M Huelse, Dmitri Kireev, et al.
Journal of Medicinal Chemistry
|
October 10, 2013
Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP
Feng Liu, Dalia Barsyte-Lovejoy, Fengling Li, et al.
Page
of 13